Prognostic value of the vasoactive-inotropic score in predicting outcomes following LVAD implantation
Elevated VIS<sub>max</sub> is a predictor of morbidity and mortality following LVAD implantation. Strategies such as preoperative hydroxocobalamin administration may mitigate postoperative vasoplegia. Further studies are warranted to refine risk stratification and optimize management for these high-risk patients.
Authors
- Thomas G. Pickering (ORCID: https://orcid.org/0009-0001-6369-3807)
- Nitin Kabra
- Aasim Afzal (ORCID: https://orcid.org/0000-0003-1557-8190)
- David Rawitscher
- Patrick Ogbue
- Akash Rusia (ORCID: https://orcid.org/0000-0001-8289-448X)
- John Michael DiMaio (ORCID: https://orcid.org/0000-0002-6064-5869)
- Timothy J. George (ORCID: https://orcid.org/0000-0003-0953-0895)
- Greg Milligan
- Kyle McCullough (ORCID: https://orcid.org/0000-0001-8984-4354)
- Cody W. Dorton (ORCID: https://orcid.org/0009-0003-5789-2986)
Institutions
- Heart Hospital Baylor Plano (US)
- Texas A&M University (US)
Publication Details
- Journal
- JHLT Open
- Published
- 2025-04-24
- DOI
- https://doi.org/10.1016/j.jhlto.2025.100272
- Primary Topic
- Mechanical Circulatory Support Devices
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Baylor Health Care System Foundation
- Robertson Foundation
- Satish and Yasmin Gupta Family Foundation